We are live on ! Find out more
BAM

Belpointe Asset Management Portfolio holdings

AUM $3.06B
1-Year Est. Return 23.82%
This Fund
S&P 500
This Quarter Est. Return
+6.89%
1 Year Est. Return
+23.82%
3 Year Est. Return
+80.11%
5 Year Est. Return
+96.42%
10 Year Est. Return
AUM
$1.39B
AUM Growth
+$221M
Cap. Flow
+$142M
Cap. Flow %
10.19%
Top 10 Hldgs %
19.64%
Holding
1,197
New
193
Increased
550
Reduced
318
Closed
68

Sector Composition

Rank Sector Weight
1 Technology 13.97%
2 Consumer Discretionary 8.03%
3 Financials 6.08%
4 Healthcare 5.93%
5 Communication Services 4.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDW icon
901
CDW
CDW
$18.1B
$168K 0.01%
1,157
+187
+19% +$32.2K
LI icon
902
Li Auto
LI
$12.5B
$168K 0.01%
4,819
+554
+13% +$13K
MNST icon
903
Monster Beverage
MNST
$92.1B
$168K 0.01%
3,676
+360
+11% +$16.9K
VGM icon
904
Invesco Trust Investment Grade Municipals
VGM
$559M
$168K 0.01%
12,015
-600
-5% -$8.31K
TECH icon
905
Bio-Techne
TECH
$11.2B
$167K 0.01%
+1,488
New +$157K
MCO icon
906
Moody's
MCO
$81.9B
$166K 0.01%
+458
New +$152K
ROP icon
907
Roper Technologies
ROP
$39.3B
$166K 0.01%
+354
New +$156K
RSG icon
908
Republic Services
RSG
$64.5B
$166K 0.01%
+1,502
New +$161K
SPHQ icon
909
Invesco S&P 500 Quality ETF
SPHQ
$19.7B
$166K 0.01%
3,410
+1,070
+46% +$49.8K
SPTI icon
910
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
$10.5B
$166K 0.01%
5,112
-8,502
-62% -$275K
TLTD icon
911
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund
TLTD
$681M
$166K 0.01%
+2,268
New +$167K
RA
912
Brookfield Real Assets Income Fund
RA
$706M
$165K 0.01%
7,535
-1,900
-20% -$41.4K
SLYG icon
913
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5.17B
$165K 0.01%
1,862
+341
+22% +$29.7K
VFC icon
914
VF Corp
VFC
$5.8B
$165K 0.01%
+2,012
New +$168K
CF icon
915
CF Industries
CF
$17.9B
$164K 0.01%
4,072
+950
+30% +$48.3K
FMAO icon
916
Farmers & Merchants Bancorp
FMAO
$472M
$164K 0.01%
+7,500
New +$171K
ZS icon
917
Zscaler
ZS
$26.3B
$164K 0.01%
825
-889
-52% -$169K
CRSP icon
918
CRISPR Therapeutics
CRSP
$4.99B
$162K 0.01%
1,000
-1,617
-62% -$197K
MFC icon
919
Manulife Financial
MFC
$74.1B
$162K 0.01%
+8,219
New +$172K
QS icon
920
QuantumScape Corp
QS
$3.4B
$162K 0.01%
+5,561
New +$180K
EFC
921
Ellington Financial
EFC
$1.65B
$161K 0.01%
8,400
-2,300
-21% -$42.5K
MTCH icon
922
Match Group
MTCH
$8.54B
$161K 0.01%
992
-176
-15% -$25.8K
DBA icon
923
Invesco DB Agriculture Fund
DBA
$1.22B
$160K 0.01%
8,595
-4,325
-33% -$79K
EW icon
924
Edwards Lifesciences
EW
$51.5B
$160K 0.01%
+1,546
New +$146K
SWBI icon
925
Smith & Wesson
SWBI
$651M
$160K 0.01%
4,593
-45,558
-91% -$954K

Similar funds

Belpointe Asset Management's Q2 2021 Portfolio in Review

As of Q2 2021, Belpointe Asset Management held 1,197 positions worth $1.39B, up 19% from $1.17B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Belpointe Asset Management deployed $142M of net new capital in Q2 2021, opening 193 new positions and adding to 550 existing holdings. Its largest new stake was VanEck Agribusiness ETF: 31,241 shares worth $2.85M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $5.78M trimmed.

  • Belpointe Asset Management's largest Q2 2021 buy was VanEck Agribusiness ETF: 31,241 shares worth $2.85M.
  • Belpointe Asset Management added most to Rareview Dynamic Fixed Income ETF in Q2 2021, an estimated $15.8M increase.
  • Belpointe Asset Management's biggest Q2 2021 reduction was Bristol-Myers Squibb, cutting an estimated $5.78M.
  • Belpointe Asset Management fully exited Schwab 5-10 Year Corporate Bond ETF in Q2 2021, selling an estimated $1.5M.
  • Belpointe Asset Management's ten largest holdings make up 20% of its $1.39B portfolio in Q2 2021.
  • Belpointe Asset Management opened 193 new positions and closed 68 in Q2 2021.
  • Belpointe Asset Management's portfolio value rose 19% quarter-over-quarter to $1.39B.

Based on Belpointe Asset Management's 13F filing for Q2 2021, filed 9 Aug 2021.